ACADIA Pharmaceuticals's total assets for Q2 2025 were $1.23B, an increase of 8.23% from the previous quarter. ACAD total liabilities were $403.17M for the fiscal quarter, a 9.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.